These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4064984)

  • 21. Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx.
    Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ
    Am J Otolaryngol; 1994; 15(4):250-7. PubMed ID: 7978023
    [No Abstract]   [Full Text] [Related]  

  • 22. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Squamous cell carcinoma of the subglottis.
    Garas J; McGuirt WF
    Am J Otolaryngol; 2006; 27(1):1-4. PubMed ID: 16360814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laser surgery for the treatment of glottic carcinomas.
    Shvero J; Koren R; Zohar L; Hadar T; Marshak G; Gal R; Feinmesser R; Segal K
    Am J Otolaryngol; 2003; 24(1):28-33. PubMed ID: 12579480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life, functional outcome, and costs of early glottic cancer.
    Smith JC; Johnson JT; Cognetti DM; Landsittel DP; Gooding WE; Cano ER; Myers EN
    Laryngoscope; 2003 Jan; 113(1):68-76. PubMed ID: 12514385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinicopathologic prognostic factors in laryngeal pharyngolaryngeal tumors. II. Glottic carcinomas].
    Suárez Nieto C; Herrera Monge F; Díaz Fernández C; Alvarez Alvarez I; Sota Equizábal E; Llorente Pendás JL; Gómez Martínez J
    Acta Otorrinolaringol Esp; 1993; 44(2):77-83. PubMed ID: 8334011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidisciplinary management of laryngeal carcinoma.
    Mendenhall WM; Mancuso AA; Hinerman RW; Malyapa RS; Werning JW; Amdur RJ; Villaret DB
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S12-4. PubMed ID: 17848278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T1 glottic carcinoma involving the posterior commissure.
    Shvero J; Shvili I; Mizrachi A; Shpitzer T; Nageris B; Koren R; Hadar T
    Laryngoscope; 2009 Jun; 119(6):1116-9. PubMed ID: 19308987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
    Ikeda Y; Tsukuda M; Tanigaki Y; Yabuki K; Mitake D; Ishitoya J
    Gan To Kagaku Ryoho; 2008 May; 35(5):789-92. PubMed ID: 18487914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
    Schrijvers ML; van Riel EL; Langendijk JA; Dikkers FG; Schuuring E; van der Wal JE; van der Laan BF
    Head Neck; 2009 Jun; 31(6):759-64. PubMed ID: 19260127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation therapy for T1 glottic cancer: involvement of the anterior commissure.
    Nozaki M; Furuta M; Murakami Y; Izawa Y; Iwasaki N; Takahashi H; Watanabe K
    Anticancer Res; 2000; 20(2B):1121-4. PubMed ID: 10810406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathologic prognostic factors of laryngeal and pharyngeal tumors. III: Supraglottic carcinoma].
    Díaz Fernández C; Suárez Nieto C; Herrero Monge F; Llorente Pendas JL; Fernández Pello M; Núñez Batalla F
    Acta Otorrinolaringol Esp; 1993; 44(3):159-64. PubMed ID: 8357626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cisplatin-fluorouracil chemotherapy in epidermoid cancers of glottic origin staged as T2].
    Laccourreye O; Bassot V; Naudo P; Jouffre V; Brasnu D; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1994; 111(5):281-91. PubMed ID: 7755306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management for stage II glottic carcinoma: radiation therapy or surgery.
    Chatani M; Yoshinobu M; Masaki N; Yoshino K
    Strahlenther Onkol; 1996 Dec; 172(12):664-8. PubMed ID: 8972751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between tumour-node-metastasis stage of laryngeal squamous cell carcinoma and duration of symptoms.
    Ozbilen S; Aydil U; Dinç AE; Kizil Y; Köybasioglu A
    J Laryngol Otol; 2006 Jun; 120(6):482-6. PubMed ID: 16608554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of EGF receptor expression in early glottic cancer.
    Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
    Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent hyperfractionated radiotherapy and carboplatin with transoral debulking microsurgery for T2N0 glottic cancer.
    Ohguri T; Imada H; Nakano K; Yahara K; Udaka T; Suzuki H; Korogi Y
    Head Neck; 2008 Aug; 30(8):1027-34. PubMed ID: 18302271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radiotherapy in glottic T1 carcinoma. Local control and survival].
    Herranz J; Fernández M; Ramos S; Vázquez Barro C; Sarandeses García A; Martínez Vidal J; Veiras C
    Acta Otorrinolaringol Esp; 2000; 51(1):57-61. PubMed ID: 10799934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage II glottic carcinoma: prognostic factors and management.
    Kaplan MJ; Johns ME; McLean WC; Fitz-Hugh GS; Clark DA; Boyd JC; Cantrell RW
    Laryngoscope; 1983 Jun; 93(6):725-8. PubMed ID: 6855395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.